Retinoblastoma, RB1 Gene Mutations Analysis
The Retinoblastoma-1 (RB1) gene is located on long (q) arm of chromosome 13 at position 14.2 and it codes for a protein; retinoblastoma-1, a tumor suppressor protein. Retinoblastoma-1 regulates DNA replication, cellular growth, cellular differentiation, cellular survival and apoptosis. Hundreds of gene mutations of RB1gene have been implicated in retinoblastoma. These mutations can be either hereditary or sporadic; when hereditary the disease follows an autosomal dominant pattern of inheritance with high degree of penetrance. Mutations in both the alleles of Rb1 gene are required for the tumorigenesis. In the hereditary variant one mutated allele is inherited and the other occurs somatically. In the sporadic type, mutations of both alleles occur somatically. Sporadic retinoblastoma is unilateral, with the mean age of diagnosis being 2 years. Children with hereditary retinoblastoma have bilateral tumors and have a mean age of diagnosis at 1 year. Patients with the hereditary form are also at greater risk of developing other tumors such as osteosarcoma and soft tissue sarcoma.
The most common initial sign of retinoblastoma is leukocoria. Other manifestations include strabismus (due to disruption of the ocular alignment) heterochromia, hyphema, glaucoma, and orbital cellulites. Advanced disease manifests with deteriorating blindness, orbital swelling and proptosis. RB-1 gene mutation has also been implicated in other cancers like lung cancer, bladder cancer, osteosarcoma, melanoma, leukemia etc.
- In diagnosis and classification of retinoblastoma
- Prenatal assessment for retinoblastoma
- To screen for retinoblastoma before IVF
- To identify at risk family members and provide proper counseling
Negative for mutation analyze (No reportable pathogenic variants were identified)
Whole Blood EDTA (Lavender).
Stability (blood)
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
Stability (Saliva)
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: up to 1 month
- Pediatr Clin North Am. 2015 Feb; 62(1):201-23. [PMID: 25435120]
- Mol Vis. 2014; 20: 545–552. [PMID: 24791139]
- Mol Vis. 2019; 25: 215–221. [PMID: 30996590]
- Asian Pac J Cancer Prev. 2014;15 (18):7863-7. [ PMID: 25292078]
- Am J Ophthalmol. 2009 Aug; 148(2):192-8. [PMID: 19477707]
- Saudi J Ophthalmol. 2010 Oct; 24(4): 119–123. [PMID: 23960888]